The impact of intravenously administered dexketoprofen trometamol on analgesia and recovery in ambulatory dilatation and curettage procedures: a retrospective analysis | ||||
Ain-Shams Journal of Anesthesiology | ||||
Volume 14, Issue 1, January 2022 PDF (985 K) | ||||
DOI: 10.1186/s42077-022-00277-4 | ||||
View on SCiNiTO | ||||
Authors | ||||
Naime Yalçın ; Ayça S. Şahin; Barış Sandal; Abdurrahim Derbent; Ziya Salihoğlu | ||||
Abstract | ||||
Background Achieving adequate pain control during and after the uterine D/C (dilatation and curettage) procedure is crucial for a good recovery process and early discharge. Results Significant differences were determined between the groups regarding the values of Ramsey sedation scores (=0.048). VAS (visual analog scale) mean values of group T were higher compared to the VAS mean values of group D (=0.02). A significant difference was found between group P and group D (=0.016), the mean VAS values of group P were higher than group D. Conclusions We found out that preemptive intravenous 25 mg dexketoprofen trometamol administered in the daily D/C procedure provides good quality postoperative analgesia with minimal adverse effects by reducing the need for rescue analgesia, and is more effective in postoperative analgesia than paracetamol and tramadol. | ||||
Keywords | ||||
Pain; Dexketoprofen trometamol; ambulatory surgery; Sedation; Uterine dilatation and curettage | ||||
Statistics Article View: 10 PDF Download: 15 |
||||